All posts in
Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster
Novartis puts the Development of two Anti-Aging Drugs in American Hands
MedTech Company Launches Large €55M IPO for Artificial Heart Valves
UPDATE: Reproductive Health Biotech starts Phase III after €90M IPO
A New Transatlantic Partnership takes on Antibiotic Resistance
Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
Interfacing the Brain & Machines: Another Step to a Cyborg Future
What Happened to the Smart Contact Lens for Diabetics?
Actelion’s key Drug linked to Deaths, prompting EMA Investigation
Swiss Antibodies and the US NIH will fight Ancient Viral DNA causing ALS
Labiotech UG, All Rights Reserved -
Send this to friend